Lola-Jade P.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Evaluation of AMG 193 Combined with Additional Therapies in Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers with Homozygous MTAP-Deletion
- Phase III Randomized Trial of AZD0901 with Capecitabine ± Rilvegostomig in First‑Line Claudin‑18.2‑Positive HER2‑Negative Advanced Gastric, GEJ or Esophageal Adenocarcinoma
- Phase II Study on the Efficacy of Pemigatinib in Recurrent or Metastatic Solid Tumors with FGFR1, FGFR2, or FGFR3 Alterations
Data & Insights
Has run more than one trial at 159 of 355 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced gastrointestinal cancers, with particular focus on cholangiocarcinoma and colorectal cancer. Their research encompasses novel therapeutic approaches for patients with specific genetic mutations.
- IDH1-mutated biliary tract cancers
- Metastatic colorectal cancer with dMMR/MSI status
- Advanced gastrointestinal tract malignancies
Their work extends to treating patients with MTAP-deleted gastrointestinal cancers.
Upper GI Malignancies
The investigator focuses on developing treatments for esophageal and gastric cancers, particularly in advanced stages. Their expertise includes managing EBV-positive gastric cancer and implementing innovative combination therapies.
- Metastatic esophageal cancer
- Advanced gastric cancer
- Immunotherapy combinations
The research includes evaluation of novel immunotherapy approaches for upper GI cancers.
Precision Oncology
The investigator conducts research in molecularly targeted therapies, focusing on specific genetic alterations. Their work includes treating patients with FGFR mutations and other genetic biomarkers.
- FGFR-altered solid tumors
- Biomarker-driven therapy
- Personalized treatment approaches
Their expertise extends to treating various solid tumors with specific genetic signatures.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
